Golimumab (anti-TNFa) is a potent human IgG1 TNFα antagonist monoclonal antibody. Golimumab (anti-TNFa) has anti-inflammation activitity and inhibits IL-6 and IL-1β production. Golimumab (anti-TNFa) acts via targeting and neutralizing TNF to prevent inflammation and destruction of cartilage and bone. Golimumab (anti-TNFa) has the anticancer activity and induces cell apoptosis. Golimumab (anti-TNFa) can be used for rheumatoid arthritis, Crohn's disease and cancer research.
规格
产品名称
Recombinant TNF-alpha Antibody, TNF-α 抑制剂
别名
戈利木单抗
英文别名
APC1 antibody|APC1 protein antibody|Cachectin antibody|DIF antibody|Differentiation inducing factor antibody|Macrophage cytotoxic factor antibody|Tnf antibody|TNF superfamily member 2 antibody|TNF superfamily, member 2 antibody|TNF, macrophage derived antibody|TNF, monocyte derived antibody|TNF-a antibody|TNF-alpha antibody|TNFA antibody|TNFSF2 antibody|Tumor necrosis factor (TNF superfamily member 2) antibody|Tumor necrosis factor alpha antibody|Tumor necrosis factor antibody|Tumor necrosis factor ligand superfamily member 2 antibody|Tumor Necrosis Factor, Membrane Form antibody|Tumor necrosis factor, soluble form antibody|APC1 protein|Cachectin|Cachetin|DIF|TNF|TNF, monocyte-derived|TNFA|TNF-A|TNFalpha|TNF-alpha|TNF-alphacachectin|TNFATNF, macrophage-derived|TNFG1F|TNFSF1A|TNFSF2|TNFSF2TNF superfamily, member 2|tumor necrosis factor (TNF superfamily, member 2)|tumor necrosis factor alpha|Tumor necrosis factor ligand superfamily member 2|tumor necrosis factor|tumor necrosis factor-alpha|CNTO-148
Golimumab (anti-TNFa) (Ab175552) - ELISA Immobilized Recombinant Human TNF-α Protein (rp156007) at 2.0 μg/mL can bind Golimumab (anti-TNFa) (Ab175552) with the EC₅₀ of 27.30 ng/mL.
Golimumab (anti-TNFa) (Ab175552) - SEC The purity of Golimumab (anti-TNFa) (Ab175552) is more than 95% verified by HPLC.